EPB41L3, TSP-1 and RASSF2 as new clinically relevant prognostic biomarkers in diffuse gliomas.
Perez-Janices N, Blanco-Luquin I, Tuñón MT, Barba-Ramos E, Ibáñez B, Zazpe-Cenoz I, Martinez-Aguillo M, Hernandez B, Martínez-Lopez E, Fernández AF, Mercado MR, Cabada T, Escors D, Megias D, Guerrero-Setas D.
Perez-Janices N, et al. Among authors: tunon mt.
Oncotarget. 2015 Jan 1;6(1):368-80. doi: 10.18632/oncotarget.2745.
Oncotarget. 2015.
PMID: 25621889
Free PMC article.